Surmodics wins FDA approval for SurVeil drug-coated balloon

Surmodics received FDA approval for its SurVeil drug-coated balloon to treat peripheral arterial disease, triggering a $27 million milestone payment from partner Abbott.

“Surmodics said Tuesday it has won Food and Drug Administration approval for the SurVeil drug-coated balloon to treat peripheral arterial disease, clearing the way for the company to receive a $27 million milestone payment from partner Abbott.”medtechdive.com

• 1 source
• medtechdive.comSurmodics secures FDA nod for PAD balloon, earning payment from Abbott | MedTech DiveSusan KellyJun 20, 2023

Summarized from public sources; check the original articles before acting on it.